Literature DB >> 2655749

Bacterial infections complicating liver disease.

R J Wyke.   

Abstract

Bacterial infection is a serious and often fatal complication of patients with liver disease and can prove fatal either directly or by precipitation of gastrointestinal bleeding, renal failure, or hepatic encephalopathy. At greatest risk are patients with alcoholic cirrhosis or decompensated chronic liver disease, or cases of acute liver disease who progress to fulminant hepatic failure or subacute hepatic necrosis. Infection appears to be unusual in patients with primary biliary cirrhosis. The site and type of infection is unrelated to the aetiology of the liver disease. Bacteraemia, pneumonia, urinary tract infection and spontaneous bacterial peritonitis are most common but infective endocarditis and meningitis, especially with pneumococci, are easily overlooked. Clinical suspicion of infection must be high as the only indication may be a general deterioration in the patients' clinical state, increasing encephalopathy or renal impairment. In the case of patients with fulminant hepatic failure, infection may precipitate the initial or recurrent encephalopathy and contributes to death in 10% of fatal cases. Spontaneous bacterial peritonitis is now recognized to occur in the absence of clinical features of peritonitis. The PMN content of the ascitic fluid may provide the only indication of infection and is the most readily available screening test. The most common types of organism responsible for all types of infection are Gram-negative enteric and streptococci, especially pneumococci, while infection with anaerobes is rare. Risk factors for infection include decompensated alcoholic liver disease, fulminant hepatic failure, gastrointestinal bleeding, invasive practical procedures and impaired host defence mechanisms against infection. Of the host defence mechanisms, impaired function of the reticuloendothelial system, complement, and PMNs represent the most common and serious defects. Defects of humoral immunity are present in ascitic fluid from patients with cirrhosis and are probably a major reason for development of spontaneous bacterial peritonitis. Diuresis improves these functions and reduces the risk of peritonitis. Treatment of infections even with the appropriate antibiotic is still associated with a high mortality but the use of adjuvant gut sterilization is promising, particularly in cases infected with Gram-negative enteric organisms. Infusions of fresh frozen plasma, blood and cryoprecipitate improve some systemic host defences and may be beneficial in the treatment and reduction of risk of infection.

Entities:  

Mesh:

Year:  1989        PMID: 2655749     DOI: 10.1016/0950-3528(89)90052-3

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  8 in total

Review 1.  Treatment of acute liver failure.

Authors:  K H Boeker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: a meta-analysis.

Authors:  Jun Wang; Xiao Dong He; You Cheng Zhang
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

Review 4.  Infectious complications of liver disease.

Authors:  P D King
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

5.  Spontaneous bacterial empyema in patients with liver cirrhosis in Upper Egypt: prevalence and causative organisms.

Authors:  Hoda A Makhlouf; Khairy Hammam Morsy; Nahed A Makhlouf; Eman Nasr Eldin; Mahmoud Khairy
Journal:  Hepatol Int       Date:  2012-05-04       Impact factor: 6.047

6.  Granulocyte colony-stimulating factor improves deficient in vitro neutrophil transendothelial migration in patients with advanced liver disease.

Authors:  Carmen Fiuza; Magdalena Salcedo; Gerardo Clemente; Jose M Tellado
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  Macrophages from patients with cirrhotic ascites showed function alteration of host defense receptor.

Authors:  Abdel Motaal M Ahmed; Abdel Gadir Y Kadaru; Ibtihal Omer; Ahmed M Musa; Khalid Enan; Isam M El Khidir; Roger Williams
Journal:  J Clin Exp Hepatol       Date:  2014-09-16

8.  Foley catheters functionalised with a synergistic combination of antibiotics and silver nanoparticles resist biofilm formation.

Authors:  Rajendran Mala; Antony Annie Aglin; Arul Selvaraj Ruby Celsia; Sivalingam Geerthika; Narbahvi Kiruthika; Chinnathambi VazagaPriya; Kumarapillai Srinivasa Kumar
Journal:  IET Nanobiotechnol       Date:  2017-08       Impact factor: 1.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.